Page results
-
Breakthroughs in Alzheimer’s disease are exciting and invigorating dementia research, and we will need to be ready to deliver new treatments as they come through, say Professor Nick Fox and Dr Catherine Mummery.
-
UCLH is pleased to present the first strategic workforce plan for University College London Hospitals NHS Foundation Trust (UCLH). Providing top quality care to all our patients is at the core of everything we do, and our diverse workforce is key to delivery.
-
Medtronic are running a series of patient webinars for anyone with Type 1 Diabetes using the MiniMed™ 780G pump or system.
-
This information is for patients who have been given a walking boot, including air cast boots, pneumatic walking boots and vacoped boots.
-
New precision therapy for bile duct cancer extends patients’ lives
-
Mr George Attilakos is a consultant in obstetrics and fetal medicine and the clinical lead for obstetrics at UCLH. Alongside managing normal pregnancies, Mr Attilakos has a special interest in the management of multiple pregnancies and high-risk pregnancies, as well as expertise in fetal medicine and fetal surgery, including in-utero treatment for congenital diaphragmatic hernia, spina bifida and twin-to-twin transfusion syndrome.
-
Professor Manjit Matharu's major research interests include migraine, trigeminal autonomic cephalalgias, facial pain, neurostimulation for intractable headaches, spontaneous intracranial hypotension and other headache disorders in hypermobility syndromes.
-
This information is for patients who have been given a hinge knee brace.
-
Information about endovascular treatments of AVMs undertaken in the NHNN angiography suite.
-
Introduction of Bordetella pertussis PCR testing at Halo laboratory (Health Services Laboratories)
File results
-
FOI/2024/0349 - Trust's operations and tele reporting services/ outsourced and insourced
-
FOI/2024/0354 - Staff details for estates and facilities
-
FOI/2024/0473 - Elective operations cancelled for non-clinical reasons 2023/24
-
FOI/2024/0478 - Elective operations cancelled for non-clinical reasons 2021/22-2023/24
-
FOI/2024/0479 - Applications or systems deployed on Microsoft Azure Cloud
-
FOI/2024/0368 - Treatment in renal cell carcinoma
-
FOI/2024/0486 - Diagnostic tests for both point of care testing and laboratory
-
FOI/2024/0482 - Medical device/ enterprise application Integration/ data warehouse systems
-
FOI/2024/0541 - Healthcare-associated infections (HAIs) 2022-2024
-
FOI/2023/0418 - GIDS service patient referrals and treatment